GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $287,000 | +12.1% | 6,549 | +11.3% | 0.01% | +30.0% |
Q1 2022 | $256,000 | -1.2% | 5,883 | 0.0% | 0.01% | +11.1% |
Q4 2021 | $259,000 | +11.6% | 5,883 | -3.3% | 0.01% | -30.8% |
Q3 2021 | $232,000 | -0.9% | 6,083 | +3.4% | 0.01% | 0.0% |
Q2 2021 | $234,000 | +11.4% | 5,883 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $210,000 | -2.8% | 5,883 | 0.0% | 0.01% | -7.1% |
Q4 2020 | $216,000 | -4.0% | 5,883 | -1.7% | 0.01% | -17.6% |
Q3 2020 | $225,000 | -4.7% | 5,983 | +3.5% | 0.02% | -15.0% |
Q2 2020 | $236,000 | +7.8% | 5,783 | 0.0% | 0.02% | -13.0% |
Q1 2020 | $219,000 | -19.5% | 5,783 | 0.0% | 0.02% | 0.0% |
Q4 2019 | $272,000 | +10.1% | 5,783 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $247,000 | +6.9% | 5,783 | 0.0% | 0.02% | +9.5% |
Q2 2019 | $231,000 | -5.3% | 5,783 | -4.9% | 0.02% | -16.0% |
Q1 2019 | $244,000 | +10.4% | 6,083 | +5.2% | 0.02% | -10.7% |
Q4 2018 | $221,000 | -9.4% | 5,783 | -4.9% | 0.03% | +12.0% |
Q3 2018 | $244,000 | -0.4% | 6,083 | 0.0% | 0.02% | +13.6% |
Q2 2018 | $245,000 | +3.4% | 6,083 | 0.0% | 0.02% | -18.5% |
Q1 2018 | $237,000 | +8.2% | 6,083 | -1.5% | 0.03% | +12.5% |
Q4 2017 | $219,000 | -12.0% | 6,177 | +1.5% | 0.02% | -17.2% |
Q3 2017 | $249,000 | -5.0% | 6,083 | 0.0% | 0.03% | -3.3% |
Q2 2017 | $262,000 | +2.7% | 6,083 | 0.0% | 0.03% | +11.1% |
Q1 2017 | $255,000 | -1.5% | 6,083 | -9.4% | 0.03% | -10.0% |
Q4 2016 | $259,000 | -1.9% | 6,717 | +10.2% | 0.03% | -6.2% |
Q2 2016 | $264,000 | +6.9% | 6,096 | 0.0% | 0.03% | +3.2% |
Q1 2016 | $247,000 | +0.4% | 6,096 | 0.0% | 0.03% | 0.0% |
Q4 2015 | $246,000 | +6.0% | 6,096 | 0.0% | 0.03% | +3.3% |
Q3 2015 | $232,000 | -8.7% | 6,096 | 0.0% | 0.03% | -3.2% |
Q2 2015 | $254,000 | -9.6% | 6,096 | 0.0% | 0.03% | -8.8% |
Q1 2015 | $281,000 | +7.7% | 6,096 | 0.0% | 0.03% | +9.7% |
Q4 2014 | $261,000 | -24.3% | 6,096 | -18.7% | 0.03% | -24.4% |
Q3 2014 | $345,000 | -14.0% | 7,496 | 0.0% | 0.04% | -16.3% |
Q2 2014 | $401,000 | -73.1% | 7,496 | -73.1% | 0.05% | -73.4% |
Q1 2014 | $1,490,000 | +0.1% | 27,896 | 0.0% | 0.18% | -5.2% |
Q4 2013 | $1,489,000 | +6.4% | 27,896 | 0.0% | 0.19% | -0.5% |
Q3 2013 | $1,400,000 | -13.3% | 27,896 | -13.6% | 0.20% | -16.7% |
Q2 2013 | $1,614,000 | – | 32,296 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |